Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | Vivoryon Therapeutics - |
Description | Targeting diseases at their molecular Vivoryon Therapeutics is a precision medicine company focused on bringing first-in-class therapies to patientssuffering from age-related |
Keywords | N/A |
WebSite | vivoryon.com |
Host IP | 77.247.87.173 |
Location | Germany |
Site | Rank |
US$3,266,833
Last updated: 2022-06-13 03:21:58
vivoryon.com has Semrush global rank of 3,239,928. vivoryon.com has an estimated worth of US$ 3,266,833, based on its estimated Ads revenue. vivoryon.com receives approximately 376,943 unique visitors each day. Its web server is located in Germany, with IP address 77.247.87.173. According to SiteAdvisor, vivoryon.com is safe to visit. |
Purchase/Sale Value | US$3,266,833 |
Daily Ads Revenue | US$3,016 |
Monthly Ads Revenue | US$90,467 |
Yearly Ads Revenue | US$1,085,594 |
Daily Unique Visitors | 25,130 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vivoryon.com. | A | 300 | IP: 77.247.87.173 |
vivoryon.com. | NS | 300 | NS Record: ns1.shdservices.com. |
vivoryon.com. | NS | 300 | NS Record: ns2.shdservices.com. |
vivoryon.com. | MX | 300 | MX Record: 10 mail.vivoryon.com. |
vivoryon.com. | MX | 300 | MX Record: 50 mail.probiodrug.de. |
vivoryon.com. | TXT | 300 | TXT Record: MS=ms89813715 |
vivoryon.com. | TXT | 300 | TXT Record: MS=6D5D014F0909F6D25ACEDBE8E3E5F705521AED07 |
vivoryon.com. | TXT | 300 | TXT Record: v=spf1 mx a:mail.orbiteam.de a:mx01.shdservices.de a:mx02.shdservices.de a:mailing1.eqs-externaladdress.com a:mailing2.eqs-externaladdress.com ip4:87.253.233.242 ip4:185.189.239.13 ip4:40.113.5.186 -all |
About Us Leadership Team Our Partners Corporate Presentation Pipeline Our Science Investors & News Stock Information News&Events Corporate Presentation Financial Information Corporate Governance Shareholders´ Meetings Email Alerts Contact Us Careers ✕ We are passionate about creating small molecule medications by building on our in-depth understanding of pathologic pathways with a single goal in mind: improving the lives of all those who are affected by severe diseases. Targeting diseases at their molecular roots Learn more Aiming to alter the course of AD Our lead candidate varoglutamstat is an orally administered small molecule inhibitor of glutaminyl cyclase (QPCT), an enzyme which catalyzes the formation of N3pE amyloid, a particularly neurotoxic molecule not found in healthy individuals that has been identified as a driver of Alzheimer’s disease (AD). Varoglutamstat is currently in Phase 2 clinical development. More about varoglutamstat Diverse pipeline addressing severe |
HTTP/1.1 301 Moved Permanently Date: Wed, 20 Oct 2021 14:45:21 GMT Server: Apache/2.4.49 (codeit) OpenSSL/1.1.1l PHP/7.4.24 X-Powered-By: PHP/7.4.24 X-Redirect-By: WordPress Location: https://www.vivoryon.com/ Cache-Control: max-age=0 Expires: Wed, 20 Oct 2021 14:45:21 GMT Vary: Accept-Encoding Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Wed, 20 Oct 2021 14:45:22 GMT Server: Apache/2.4.49 (codeit) OpenSSL/1.1.1l PHP/7.4.24 X-Powered-By: PHP/7.4.24 Last-Modified: Wed, 20 Oct 2021 03:45:46 GMT Cache-Control: max-age=0 Expires: Wed, 20 Oct 2021 14:45:22 GMT Vary: Accept-Encoding Content-Type: text/html; charset=UTF-8 |
Domain Name: VIVORYON.COM Registry Domain ID: 2374421734_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.puredomain.com Registrar URL: http://www.variomedia.de Updated Date: 2021-03-30T07:17:53Z Creation Date: 2019-03-29T14:30:59Z Registry Expiry Date: 2022-03-29T14:30:59Z Registrar: Variomedia AG Registrar IANA ID: 1257 Registrar Abuse Contact Email: abuse@variomedia.de Registrar Abuse Contact Phone: +49.33123789-0 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.SHDSERVICES.COM Name Server: NS2.SHDSERVICES.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T04:10:04Z <<< |